Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 15850786624 |
| E-mail: | sales@cqpharm.com |
| QQ: | 3622483400 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 5-Bromo-4,7-diazaindole | C6H4BrN3 | 875781-43-4 | Details |
| Cabotegravir | C19H17F2N3O5 | 1051375-10-0 | Details |
| 4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione | C15H13N3S | 1533519-84-4 | Details |
| 2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexene-1-carboxaldehyde | C15H17ClO | 1228837-05-5 | Details |
| 3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)benzenesulfonamide | C12H17N3O5S | 1228779-96-1 | Details |
| 1426129-50-1 enantioMer | C20H25NO3 | 153037-40-2 | Details |
| Treprostinil intermediate 2 | C16H33O5P | 101691-98-9 | Details |
| (2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid | C23H29NO4 | 1012341-54-6 | Details |
| ABT199 intermediates | C15H11FN2O3 | 1235865-75-4 | Details |
| Selonsertib | C24H24FN7O | 1448428-04-3 | Details |
| C21H22N4O3 | 1050477-30-9 | Details |
| Pimodivir (VX-787) | C20H19F2N5O2 | 1629869-44-8 | Details |
| Ibrutinib | C25H24N6O2 | 936563-96-1 | Details |
| Rolapitant | C25H26F6N2O2 | 552292-08-7 | Details |
| Aprocitentan;ACT-132577 | C16H14Br2N6O4S | 1103522-45-7 | Details |
| 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine dihydrochloride | C19H28Cl2N2 | 1628047-87-9 | Details |
| 4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide | C21H22N4O3 | 1050477-27-4 | Details |
| N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide | C18H21BN2O3 | 1383385-64-5 | Details |
| Upadacitinib intermediate2 | C18H20N4O4S | 1201187-44-1 | Details |
| Abrocitinib | C14H21N5O2S | 1622902-68-4 | Details |
| Valbenazine tosylate | C31H46N2O7S | 1639208-54-0 | Details |
| (2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropoxy)benzylidene)-2-(propyliMino)-3-(o-tolyl)thiazolidin-4-one | C23H25ClN2O4S | 854107-55-4 | Details |
| Talazoparib | C19H14F2N6O | 1207456-01-6 | Details |
| Acalabrutinib | C26H23N7O2 | 1420477-60-6 | Details |
| Relugolix intermediate1 | C17H18N2O6S | 308831-93-8 | Details |
| Relugolix intermediate4 | C26H27F2N3O6S | 1589503-97-8 | Details |
| (2-Fluoro-6-(trifluoromethyl)phenyl)methanamine hydrochloride | C8H8ClF4N | 643088-07-7 | Details |
| Galeterone | C26H32N2O | 851983-85-2 | Details |
| N-[(1S)-3-Methyl-1-[[(2R)-2-Methyl-2-oxiranyl]carbonyl]butyl]-CarbaMic acid, 1,1-diMethylethyl ester | C14H25NO4 | 247068-82-2 | Details |
| 5-Biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methyl-pent-2-enoic acid | C23H27NO4 | 1012341-48-8 | Details |
| Methyl 2-[[4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetate | C18H17N3O2S | 1533519-85-5 | Details |
| 5-Hydroxy-7-azaindole | C7H6N2O | 98549-88-3 | Details |
| 1-(2-fluoro-6-(trifluoromethyl)benzyl)-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione | C13H9F4IN2O2 | 1150560-54-5 | Details |
| 1-(2-Fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione | C13H10F4N2O2 | 830346-47-9 | Details |
| Gefapixant | C14H19N5O4S | 1015787-98-0 | Details |
| Relugolix | C29H27F2N7O5S | 737789-87-6 | Details |
| MGL-3196 | C17H12Cl2N6O4 | 920509-32-6 | Details |
| Lumicitabine | C18H25ClFN3O6 | 1445385-02-3 | Details |
| Vilaprisan | C27H29F5O4S | 1262108-14-4 | Details |
| 2-Fluoro-3-Methoxyphenylboronic acid | C7H8BFO3 | 352303-67-4 | Details |
| (3-Chloropyrazin-2-yl)MethanaMine hydrochloride | C5H7Cl2N3 | 939412-86-9 | Details |
| Filgotinib (GLPG0634) | C21H23N5O3S | 1206161-97-8 | Details |
| BMN 673 | C19H14F2N6O | 1207456-00-5 | Details |
| Rosiptor;AQX-1125 | C20H35NO2 | 782487-28-9 | Details |
| (2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester | C18H18BrN5O2 | 1420478-88-1 | Details |
| Upadacitinib | C17H19F3N6O | 1310726-60-3 | Details |
| (S)-1-Boc-3-hydroxypiperidine | C10H19NO3 | 143900-44-1 | Details |
| N-Tosyl-5-bromo-4,7-diazaindole | C13H10BrN3O2S | 1201186-54-0 | Details |
| Sacubitril | C24H29NO5 | 149709-62-6 | Details |
| ABT-199 | C45H50ClN7O7S | 1257044-40-8 | Details |
| (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid | C23H29NO4 | 1012341-50-2 | Details |
| tert-butyl 4-((4'-chloro-5,5-diMethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)Methyl)piperazine-1-carboxylate | C24H35ClN2O2 | 1228780-71-9 | Details |
| Daprodustat | C19H27N3O6 | 960539-70-2 | Details |
| 2-Fluoro-6-(trifluoromethyl)benzylamine | C8H7F4N | 239087-06-0 | Details |
| Methyl 2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazin-1-yl]benzoate | C34H37ClN4O3 | 1235865-76-5 | Details |
| (R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride | C22H23ClN6O | 1701403-10-2 | Details |
| Baloxavir marboxil | C27H23F2N3O7S | 1985606-14-1 | Details |
| Risdiplam | C22H23N7O | 1825352-65-5 | Details |
| 4-(Pyridin-2-yl)aminocarbonylphenylboronicacid | C12H11BN2O3 | 850568-25-1 | Details |
| 5-bromo-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione | C13H9BrF4N2O2 | 830346-48-0 | Details |
| 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine; | C17H13N5O | 330786-24-8 | Details |
| AHU-377 (heMicalciuM salt) | C48H56CaN2O10 | 1369773-39-6 | Details |
| 3-(1-Biphenyl-4-ylMethyl-3-ethoxycarbonyl-1-butylcarbaMoyl)propionate-3'-Methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylMethyl)aMino)butyrate | C48H58N6O8 | 936623-90-4 | Details |
| Benzonitrile, 5-[3-[(1S)-2,3-dihydro-1-[(2-hydroxyethyl)aMino]-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-(1-Methylethoxy)- (HCl salt) | C23H25ClN4O3 | 1306760-85-9 | Details |
| Lemborexant | C22H20F2N4O2 | 1369764-02-2 | Details |
| Finerenone | C21H22N4O3 | 1050477-31-0 | Details |
| Treprostinil intermediate 1；(4-Hydroxy-nonyl)-phosphonic acid dimethyl ester | C11H25O4P | 1593674-47-5 | Details |
| Voxelotor ;GBT 440 | C19H19N3O3 | 1446321-46-5 | Details |
| Valbenazine | C24H38N2O4 | 1025504-45-3 | Details |
| (S)-benzyl 2-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate | C18H16BrClN4O2 | 1420478-87-0 | Details |
| Vadadustat | C14H11ClN2O4 | 1000025-07-9 | Details |
| Ethyl 2-amino-4-methyl-5-(4-nitro-phenyl)-thiophene-3-carboxylate | C14H14N2O4S | 174072-89-0 | Details |
| BMS-986165 | C20H22N8O3 | 1609392-27-9 | Details |
| brivaracetam | C11H20N2O2 | 357336-20-0 | Details |
| (4-chloro-3-(4-ethoxybenzyl)phenyl)((3aS,5R,6S,6aS)-6-hydroxy- | C23H25ClO6 | 1103738-30-2 | Details |
| 4-cyclopropylnaphthalen-1-aMine hydrochloride | C13H14ClN | 1533519-92-4 | Details |
| 1-[[2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazine | C19H27ClN2 | 1228780-72-0 | Details |
| Relugolix intermediate3 | C24H21BrF2N2O6S | 308831-95-0 | Details |
| SAGE-217 | C25H35N3O2 | 1632051-40-1 | Details |
| ARN-509 | C21H15F4N5O2S | 956104-40-8 | Details |
| Elagolix sodium | C32H29F5N3NaO5 | 832720-36-2 | Details |
| (2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoate | C20H26ClNO2 | 149690-12-0 | Details |
| 5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione | C20H15F5N2O3 | 1150560-59-0 | Details |
| 1012341-48-8 enantioMer | C23H27NO4 | 1015037-46-3 | Details |
| Relugolix intermediate2 | C24H22F2N2O6S | 308831-94-9 | Details |
| Upadacitinib intermediate5 | C16H20BrNO3 | 1428243-26-8 | Details |
| (3R,4S)-1-((benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid Dicyclohexylamine Salt | C27H42N2O4 | 2095311-49-0 | Details |
| Relugolix intermediate5 | C24H23F2N3O6S | 1589503-95-6 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||